A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants

Autor: Martinon-Torres, Federico, Gimenez-Sanchez, Francisco, Bernaola-Iturbe, Enrique, Diez-Domingo, Javier, Jiang, Qin, Perez, John L.
Zdroj: In Vaccine 8 September 2014 32(40):5206-5211
Databáze: ScienceDirect